Skip to main content
. 2018 Apr 18;15(6):5528–5536. doi: 10.3892/etm.2018.6077

Table V.

Relationship between BODE index and clinical pathology after treatment in the anti GER group.

Variables 0 1 2 3 P-value
Age (years) 0.198
  ≤55 4 21 9 3
  >55 5 21 2 1
Sex 0.612
  Male 6 29 8 4
  Female 3 13 3 0
Course of disease (years) 5.60±0.92 6.42±1.54 7.30±1.25 7.64±0.96 <0.001
Smoke (yes/no) 5/4 31/11 10/1 2/2 0.237
BMI 0.525
  ≤21 3 19 6 3
  >21 6 23 5 1
PaCO2 (mmHg) 0.677
  ≤40 5 19 5 3
  >40 4 23 6 1
PaO (mmHg) 0.375
  ≤60 1 16 3 2
  >60 8 26 8 2
Plasma albumin (g/l) 34.27±0.71 34.20±0.47 34.15±0.54 34.18±0.50 0.654
Times of AECOPD (times/years) 2.22±1.48 2.60±1.06 2.73±1.27 3.00±2.45 <0.001

BMI, body mass index; BODE, Body mass index, obstruction, dyspnea, exercise; AECOPD, acute exacerbation of chronic obstructive pulmonary disease; GER, gastroesophageal reflux.